Panacea Index Logo

Command Palette

Search for a command to run...

Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs?

Diabetes care
May 1, 1996
M Parillo et al. (5 authors)
Clinical TrialComparative StudyControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to compare the effects of a high-carbohydrate diet on blood glucose and plasma lipids in NIDDM patients with varying degrees of glucose intolerance.

Results Summary

The high-carbohydrate diet significantly increased postprandial blood glucose in patients on glibenclamide and raised fasting plasma triglyceride concentrations in both groups, but had no effect on fasting plasma cholesterol or HDL. Postprandial insulin levels increased significantly in the diet-only group.

Population

Eighteen NIDDM patients (9 on diet alone, 9 on diet plus glibenclamide).

Effective Dosage

60% energy from carbohydrate, 20% from fat (high-carbohydrate diet); 40% energy from carbohydrate, 40% from fat (low-carbohydrate diet).

Duration

15 days per diet phase (crossover design).

Interactions

Interaction noted with glibenclamide (increased postprandial blood glucose).

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
high-carbohydrate/low-fiber diet
increase
postprandial blood glucose
patients on glibenclamide
13.6 +/- 1.4 vs. 11.0 +/- 1.8 mmol/l
produced a significant increase
#1
high-carbohydrate/low-fiber diet
no change
postprandial blood glucose
group on diet alone
9.7 +/- vs. 8.9 +/- 0.6 mmol/l
no difference was recorded
#2
high-carbohydrate/low-fiber diet
increase
Postprandial insulin levels
group on diet alone
248 +/- 32 vs. 192 +/- 28 pmol/l
were significantly higher
#3
high-carbohydrate/low-fiber diet
no change
Postprandial insulin levels
other group
226 +/- 19 vs. 202 +/- 24 pmol/l
no significant differences were observed
#4
high-carbohydrate/low-fiber diet
increase
fasting plasma triglyceride concentrations
both groups
1.36 +/- 0.2 vs. 1.12 +/- 0.2 mmol/l and 1.4 +/- 0.3 vs. 1.1 +/- 0.1 mmol/l
induced a significant increase
#5
high-carbohydrate/low-fiber diet
no change
fasting plasma cholesterol and HDL
both groups
-
No differences were observed
#6
Abstract

OBJECTIVE: To compare the effects of a nigh-carbohydrate diet on blood glucose and plasma lipids in NIDDM patients with either mild or severe glucose intolerance. RESEARCH DESIGN AND METHODS: A crossover design with a 15-day intervention diet was used. Eighteen patients were separated into two groups on the basis of hypoglycemic treatment (diet, n = 9, or diet plus glibenclamide, n = 9) and were assigned to a 15-day treatment with a high-carbohydrate/low-fiber diet containing 60% energy from carbohydrate and 20% from fat or a low-carbohydrate/low-fiber diet with 40% energy from carbohydrate and 40% from fat and then crossed over to the other diet for 15 more days. RESULTS: The high-carbohydrate diet produced a significant increase in postprandial blood glucose in patients on glibenclamide (13.6 +/- 1.4 vs. 11.0 +/- 1.8 mmol/l, P < 0.002, while no difference was recorded in the group on diet alone (9.7 +/- vs. 8.9 +/- 0.6 mmol/l). Postprandial insulin levels were significantly higher after the high-carbohydrate diet in the group on diet along (248 +/- 32 vs. 192 +/- 28 pmol/l, P < 0.01), while no significant differences were observed in the other group (226 +/- 19 vs. 202 +/- 24 pmol/l) The high-carbohydrate diet also induced a significant increase in fasting plasma triglyceride concentrations in both groups (1.36 +/- 0.2 vs. 1.12 +/- 0.2 mmol/l, P < 0.05 and 1.4 +/- 0.3 vs. 1.1 +/- 0.1 mmol/l, P < 0.05). No differences were observed in fasting plasma cholesterol and HDL. CONCLUSIONS: The effects of the high-carbohydrate diet on blood glucose control in NIDDM patients differ according to severity of glucose intolerance.

Medical Subject Headings (MeSH)
BiomarkersBlood GlucoseCross-Over StudiesDiabetes Mellitus, Type 2Dietary CarbohydratesDietary FatsGlyburideGlycated HemoglobinHumansHypoglycemic AgentsMiddle Aged
Study Links
Quality Scores
Safety65
Efficacy70/10
Quality75/10
Citation Metrics
Total Citations29
Citations/Year1.0
Relative Citation Ratio0.89
NIH Percentile45.9%
Research Impact Scores
APT Score0.50
Weight Score0.48
Normalized Score0.69
Related Supplements
Does a high-carbohydrate diet have different effects in NIDD... | Panacea Index